Option Care Health OPCH 深 沪
等待开盘 10-15 09:30:00 美东时间
31.12
+0.020
+0.06%
华盛通- 最 高31.15
- 今 开31.11
- 成交量 493.15万股
- 最 低 31.09
- 昨 收 31.10
- 总市值 46.62亿
- 52周最高 36.80
- 市盈率 静 24.49
- 换手率 3.29%
- 52周最低 18.01
- 委 比 -64.68%
- 总股本 1.50亿
- 历史最高 70.48
- 量 比 0.55
- 振 幅 0.19%
- 历史最低 3.92
- 每 手 1
- 风险率 4.80%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多CCC Intelligent could see $10-$12 a share in a takeout - analyst
CCC Intelligent Solutions (CCC) could see as much as $10-$12 a share in a sale after a report on Friday that GTCR and Elliott Investment Management were in advanced talks to acquire the car-insurance ...
10-14 04:41
Are OPCH, PCRX, RXO, BOLD Obtaining Fair Deals for their Shareholders?
Insiders may stand to receive substantial financial benefits not available to ordinary shareholders. The proposed transactions may contain terms that could limit superior competing offers. S...
10-13 08:50
美股大行评级 | 潜在涨幅91.5%！巴克莱上调Vertical Aerospace评级至"标配"，目标价下调至1美元
今日重点评级关注：巴克莱：上调Vertical Aerospace评级至"标配"，目标价从2美元降至1美元；巴克莱：维持Bitdeer Technologies"超配"评级，目标价从15美元升至17美元
10-12 14:52
本周全球十大并购（10.5-10.11）
以下为本周全球十大并购（2026.10.5-2026.10.11）： 1、Cenovus Energy以约57亿加元（约41亿美元）收购Athabasca O...
10-11 10:00
美股牛股 | OPCH劲升逾32%！获58亿美元收购要约；谷歌签下科技史上最大核能协议，核电股CEG升逾12%，VST升近11%
OPCH劲升逾32%！获58亿美元收购要约；Ciena升近14%，隔夜光通信概念齐收高；谷歌签下科技史上最大核能协议，核电股CEG升逾12%，VST升近11%>>
10-07 19:00
美股收盘：标普、纳指均创历史新高！光通信走强，诺基亚涨超7%，康宁涨超6%
标普、纳指均创历史新高！光通信走强，诺基亚涨超7%，康宁涨超6%，迈威尔科技涨超5%，思科涨超4%；存储概念跌幅居前，西部数据、SK海力士跌超6%>>
10-07 08:52
盘前：纳指期货涨0.62% 美债收益率回落
受科技龙头上涨、美债收益率与油价双双下行的推动，美股股指期货周二走高。 截至发稿，道指期货涨0.71%，标普500指数期货涨0.50%，纳指期货涨0....
10-06 20:30
Option Care Health shares are trading higher following reports suggesting McKesson and Clayton Dubilier & Rice are nearing a deal to acquire the company.
Option Care Health shares are trading higher following reports suggesting McKesson and Clayton Dubilier & Rice are nearing a deal to acquire the company.
10-06 04:07
美股大行评级 | 绩后重锤！Meta惨遭16家大行下调目标价；高通、Arm、泛林集团、波士顿科学也遭多家大行下调目标价
今日重点评级关注：HC Wainwright & Co.：维持TOMI Environmental Solutions"买入"评级，目标价从3.5美元升至7美元；Canaccord Genuity：维持Viking Therapeutics"买入"评级，目标价从107美元升至114美元
07-31 11:43
